NYSE - Delayed Quote ? USD Inspire Medical Systems, Inc. (INSP) Follow Compare 175.28 +2.58 (+1.49%) At close: November 18 at 4:00 PM EST 174.42 -0.86 (-0.49%) After hours: November 18 at 6:56 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Inside a $400 billion bet on the brain-computer interface revolution Morgan Stanley's latest report pegs the BCI market at $400 billion — signaling to investors that this revolutionary technology is the next big bet in medtech. Yahoo Finance ? 17 hours ago IRTC PEN NVRO UPDATED – Inspire Medical Systems, Inc. to Present?at Jefferies London Healthcare Conference MINNEAPOLIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Inspire is scheduled to present at 7:30 a.m. Eastern Time. The presentation will be accessible via a GlobeNewswire ? 3 days ago INSP +1.49% Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced that it entered into an accelerated share repurchase (“ASR”) transaction under an agreement with Goldman Sachs & Co. LLC, to repurchase an aggregate of $75.0 million of shares of the Company’s commo GlobeNewswire ? 7 days ago INSP +1.49% Earnings Beat: Inspire Medical Systems, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models A week ago, Inspire Medical Systems, Inc. ( NYSE:INSP ) came out with a strong set of quarterly numbers that could... Simply Wall St. ? 11 days ago INSP +1.49% Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a GlobeNewswire ? 12 days ago INSP +1.49% Inspire Medical price target raised to $198 from $187 at Wells Fargo Wells Fargo raised the firm’s price target on Inspire Medical (INSP) to $198 from $187 and keeps an Equal Weight rating on the shares. The firm notes Inspire reported Q3 sales/EPS ahead of Street expectations and raised 2024 sales/EPS guidance. Q4 sales outlook is slightly softer due to hurricane/IV shortage headwinds, Wells adds. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read TipRanks ? 12 days ago INSP +1.49% Declining Stock and Decent Financials: Is The Market Wrong About Inspire Medical Systems, Inc. (NYSE:INSP)? With its stock down 7.4% over the past month, it is easy to disregard Inspire Medical Systems (NYSE:INSP). However, the... Simply Wall St. ? 12 days ago INSP +1.49% INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the third quarter. Zacks ? 13 days ago INSP +1.49% DGX BSX Inspire Medical Systems Inc (INSP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... Inspire Medical Systems Inc (INSP) reports a 33% revenue increase and strategic expansions, while addressing potential Q4 headwinds and product advancements. GuruFocus.com ? 14 days ago INSP +1.49% Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. Zacks ? 14 days ago INSP +1.49% Inspire Medical Systems (INSP) Q3 Earnings and Revenues Surpass Estimates Inspire (INSP) delivered earnings and revenue surprises of 900% and 2.81%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 14 days ago INSP +1.49% Inspire Medical Systems, Inc. Announces Third Quarter 2024?Financial Results and Updates 2024 Outlook Inspire Reports Year-over-Year Revenue Growth of 33% and Earnings per Share of $0.60 in the Third QuarterMINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2024. Recent Business Highlights Generated r GlobeNewswire ? 14 days ago INSP +1.49% Seeking Clues to Inspire (INSP) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics Evaluate the expected performance of Inspire (INSP) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. Zacks ? 19 days ago INSP +1.49% Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference MINNEAPOLIS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live GlobeNewswire ? 19 days ago INSP +1.49% Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell Medical Systems, 10x Genomics and Omnicell have been highlighted in this Industry Outlook article. Zacks ? 21 days ago OMCL ^GSPC TXG Inspire (INSP) Upgraded to Buy: What Does It Mean for the Stock? Inspire (INSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Zacks ? last month INSP +1.49% Is Inspire Medical Systems, Inc. (NYSE:INSP) The Top Stock With Improving Technical Ratings According To Piper Sandler? We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where Inspire Medical Systems, Inc. (NYSE:INSP) ranks among the list of stocks with improving technical rating according to Piper Sandler. The start of October has seen another wild swing for markets. September’s second […] Insider Monkey ? last month INSP +1.49% Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024 MINNEAPOLIS, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2024 after the close of trading on Monday, November 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Ins GlobeNewswire ? last month INSP +1.49% Vanguard Group Inc's Strategic Acquisition in Inspire Medical Systems Inc On September 30, 2024, Vanguard Group Inc, a prominent investment management firm, expanded its portfolio by acquiring an additional 362,537 shares of Inspire Medical Systems Inc (NYSE:INSP). This transaction, executed at a price of $211.05 per share, increased Vanguard's total holdings in the company to 3,232,138 shares, representing a 10.83% ownership stake. This move underscores Vanguard's strategic investment approach and confidence in Inspire Medical Systems' market potential. GuruFocus.com ? last month INSP +1.49% Inspire Medical Systems (NYSE:INSP) shareholders have earned a 31% CAGR over the last five years The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company... Simply Wall St. ? last month INSP +1.49% Performance Overview Trailing total returns as of 11/18/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return INSP S&P 500 YTD -13.84% +23.56% 1-Year +24.98% +30.56% 3-Year -35.52% +25.70%
